Insider Trading30 Sept 2026, 08:21 pm
Beryl Drugs Closes Trading Window for Q2 FY27 Results
AI Summary
Beryl Drugs Ltd has announced the closure of its trading window for all board members, promoters, and designated connected persons. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's code of conduct. The trading window will remain shut from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ended September 30, 2026. The exact date of the board meeting to approve these results will be communicated separately.
Key Highlights
- Trading window closed for insiders from Oct 1, 2026.
- Closure is for Q2 FY27 unaudited financial results.
- Effective until 48 hours post-results declaration.
- Compliance with SEBI insider trading regulations.
- Board meeting date for results to be announced later.
Price Impact
More from BERLDRG